CNCEC(SH:601117) Chang Jiang Shang Bao·2025-06-19 23:56Core Insights - China Chemical's business expansion aligns with expectations, with a total contract amount of approximately 150.8 billion yuan signed in the first five months of the year [2][3] - The company has a strong presence in over 80 countries and regions globally, with foreign market revenue accounting for about 20% in both 2023 and 2024 [2] - The company has invested over 18 billion yuan in R&D over the past three years, resulting in 5,730 authorized patents by the end of 2024 [2][14] Contract Details - In the first five months, China Chemical signed 1,829 contracts totaling 150.83 billion yuan, with 1,162 construction contracts amounting to 145.33 billion yuan, representing 63.53% and 96.36% of the total respectively [4][5] - The core chemical engineering business accounted for 1,169 billion yuan of the new contracts, making up 77.51% of the total contract amount [4][5] - Domestic and foreign market contracts amounted to 1,310.24 billion yuan and 198.01 billion yuan, respectively, with shares of 86.87% and 13.13% [5] Financial Performance - From 2018 to 2024, the company has achieved continuous growth in revenue and net profit for seven consecutive years [10][11] - In Q1 of this year, the company reported a net profit attributable to shareholders of 1.445 billion yuan, an increase of over 18% year-on-year [2][11] - The company’s total revenue for 2024 is projected to reach 186.61 billion yuan, with a year-on-year growth of 6.89% in the chemical engineering business [5][7] R&D and Innovation - The company emphasizes R&D as a driver for steady growth, with a total R&D investment of 183.56 billion yuan from 2022 to 2024 [14] - The company has developed key technologies in green environmental protection and hydrogen utilization, addressing critical technology bottlenecks [13][14] - The workforce includes 5,824 R&D personnel, accounting for 11.42% of the total staff [14]